On June 11, 2015, after the market close, TriMas Corp. (NASDAQ: TRS) announced record and distribution dates for the spin-off of its Cequent businesses, which will be renamed Horizon Global Corporation. Shareholders of record as of June 25, 2015 will receive two shares of Horizon Global common stock for every five shares of the Company’s common stock owned. When-issued trading is expected to begin on the NYSE on or about June 23, 2015 under the symbol “HZN,” and will continue through the distribution date of June 30, 2015. Regular-way trading is expected to begin on July 1, 2015, the first trading day following the distribution date. Horizon Global Corporation is expected to list its common shares on the New York Stock Exchange (NYSE) under the symbol “HZN.”
Pre-spin fair value estimates for TriMas and Horizon Global Corporation have been adjusted to reflect updated balance sheet information for the quarter ended March 30, 2015 (debt increased slightly at both entities). The pre-spin fair value estimate for TriMas has been revised to $22 (from $23 previously) and that of Horizon Global to $9 (from $10 previously), resulting in a pre-spin sum-of-the-parts fair value estimate of $31 (versus $33 previously). The post-spin fair value estimate for Horizon Global has been revised to $22 per share, based on post-spin fully-diluted share count of approximately 18.1 million shares (reflecting a 2:5 distribution), $5 million in cash and cash equivalents, and $146 million in debt .
While TriMas has experienced strong sales growth (11.4% CAGR over the past three years), well above industrial mid-cap peers, the company’s profitability metrics (EBITDA and operating margin, and EPS and free cash flow growth) have underperformed peers. With return on invested capital (ROIC) at 7.7%, versus an almost 9% weighted average cost of capital (WACC), TriMas must make its previous acquisitions ($383 million in 2014) pay off for shareholders. Revenue and earnings growth are important components that constitute the relative valuation for a diversified industrial company, but to create value for shareholders, TriMas must sustainably earn its cost of capital over the intermediate to long term. Since the company is not currently in a position to return capital to shareholders via share repurchases, the most effective means of expanding ROIC is to exceed its WACC through a significant improvement in profitability. Accordingly, since 2014, TriMas has shifted its strategic focus from revenue growth to margin improvement, including implementing several streamlining initiatives such as manufacturing relocations and cost reduction. The spin-off of Cequent should further improve profitability metrics given the spin entity’s relatively weaker profitability (6% operating margin in 2014). From 2014 to 2018, TriMas is projecting an operating profit growth at a 14% to 16% CAGR, with 2% to 3% of this estimate potentially derived from additional acquisitions. This growth would result in TriMas’ operating profit margin increasing from 9.8% in 2014 to 15% by 2018. In particular, TriMas’ packaging business (which comprises approximately 40% of the post-spin company’s sales mix and generates operating margins of 22% to 24%) appears to be on the cusp of significant new product introductions which should greatly reduce the complexity and cost of its specialty dispensing systems. With collocated factories adjacent to its largest customers, TriMas packaging has differentiated its ability to drive value on cost, product innovation, and delivery.
TRS shares have enjoyed a strong recent run (approximately 7% since May), suggesting investors have come to appreciate the more focused product portfolio of the post-spin parent, coupled with a continued operating margin expansion story. However, with the fair value estimate suggesting 3% potential upside from the current share price ($30 at the time of this writing), the shares appear to be approaching a full valuation. At the post-spin fair value of $22, TriMas would implicitly trade at 10x estimated 2015 EBITDA of $166 million, a premium to the shares’ 5-year historical average of 8.6x, and in line with the peer average of 10x, suggesting the valuation largely reflects the company’s operational transformation. Please refer to the TriMas Spin-Off Report dated May 1, 2015, for more details.